Gérard Tobelem
Direktor/Vorstandsmitglied bei OSE IMMUNOTHERAPEUTICS
Ursprung des Netzwerks ersten Grades von Gérard Tobelem
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 31 | |
| Subsidiary | Medical Specialties | 8 | |
Dendrogenix SA
 Dendrogenix SA Pharmaceuticals: MajorHealth Technology Dendrogenix SA is a Belgian Belgium-based biotech company founded in 2018 that designs, develops, and brings proprietary molecules called dendrogenins to patients in the fields of hearing loss and neurology. The company is based in Liege, Belgium. Dendrogenins are cholesterol derivatives that stimulate cell differentiation in the immune and nervous system and induce growth of dendrites on dendritic cell and neuron precursors. The company has developed strong know-how in the chemical and biological aspects of dendrogenins. The company was founded by Stéphane Silvente, Gérard Tobelem, and Philippe Lefèbvre, with Stéphane Silvente serving as CEO since 2018.
6
| Holding Company | Pharmaceuticals: Major | 6 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Gérard Tobelem
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| École des Hautes Études Commerciales de Paris | College/University | Masters Business Admin Undergraduate Degree Masters Business Admin Undergraduate Degree Masters Business Admin Masters Business Admin | |
| ABIVAX | Pharmaceuticals: Other | Founder Director/Board Member Director/Board Member Director/Board Member | |
| VALERIO THERAPEUTICS | Pharmaceuticals: Major | Chief Executive Officer Founder Chief Tech/Sci/R&D Officer | |
Seventure Partners SA
 Seventure Partners SA Investment ManagersFinance Seventure Partners SA (Seventure) is a Venture Capital firm, a subsidiary of Natixis SA founded in 1997. Seventure Partners SA is headquartered in Paris. | Investment Managers | Chief Executive Officer Chief Executive Officer | |
| ESSEC Business School | College/University | Undergraduate Degree Masters Business Admin | |
| University of Lyon | College/University | Doctorate Degree Undergraduate Degree | |
| PHAXIAM THERAPEUTICS S.A. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| Spikimm SAS | Chairman Chief Executive Officer | ||
Institut Mérieux SA
 Institut Mérieux SA BiotechnologyHealth Technology Institut Mérieux SA provides solutions for multifactorial management of diseases. The firm provides solutions for diseases, including tuberculosis, liver cancer and hepatitis. It specializes in the field human and veterinary of vaccines. It operates under the activities of diagnostics, immunotherapy and nutrition. The company was founded by Marcel Mérieux in 1897 and is headquartered Lyon, France. | Biotechnology | Director/Board Member Corporate Secretary | |
Paul Capital Partners LP
 Paul Capital Partners LP Investment ManagersFinance Founded in 1991 by Philip Paul, Paul Capital Partners LP is a private equity firm located in San Francisco with additional offices in New York City, Hong Kong, London, Paris and São Paulo. | Investment Managers | Private Equity Investor Corporate Officer/Principal | |
MaSTherCell SA
 MaSTherCell SA BiotechnologyHealth Technology MaSTherCell SA engages in providing cell therapy manufacturing services. The company was founded in 2011 and is headquartered in Charleroi, Belgium. | Biotechnology | Director/Board Member Founder | |
France Biotech Association
 France Biotech Association Miscellaneous Commercial ServicesCommercial Services France Biotech Association is an independent association founded in 1997 that brings together healthtech entrepreneurs and their expert partners. The non-profit company is based in Paris, France. The association actively contributes to meeting the many challenges of the healthtech industry, such as companies' financing, innovation-related taxes, regulatory and market access related issues. It offers concrete competition and solutions through its commissions and working groups to help startups and SMEs become international leaders capable of rapidly developing and bringing innovative solutions to patients. The French company was founded by Philippe Pouletty, Pascal Brandys, Denis J. Lucquin. | Miscellaneous Commercial Services | Founder Chairman | |
Institut National de la Santé & de la Recherche Médicale
 Institut National de la Santé & de la Recherche Médicale Miscellaneous Commercial ServicesCommercial Services Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Centre National de la Recherche Scientifique
 Centre National de la Recherche Scientifique General GovernmentGovernment Centre National de la Recherche Scientifique provides scientific research services. The firm engages in the research capable of advancing knowledge and bringing social, cultural, and economic benefits for society. The company was founded in 1939 and is headquartered in Paris, France. | General Government | Corporate Officer/Principal Corporate Officer/Principal | |
| Université Catholique de Louvain | College/University | Doctorate Degree Doctorate Degree | |
| OSE Pharmaceuticals | Director/Board Member Chief Executive Officer | ||
PROMETHERA Biosciences SA
 PROMETHERA Biosciences SA Pharmaceuticals: MajorHealth Technology PROMETHERA Biosciences SA discovers, develops and commercializes cell therapy products to treat liver diseases. It operates as a pharmaceutical company that develops treatment based on allogeneic adult stem cell technology. The firm’s technology platform is based on a newly discovered cell type, isolated from normal human adult liver tissue: Heterologous Human Adult Liver Progenitor Cells (HHALPC). The company was founded by Etienne Marc Sokal and Eric Halioua on February 12, 2009 and is headquartered in Mont-Saint-Guibert, Belgium. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
Horama SA
 Horama SA BiotechnologyHealth Technology Horama SA engages in the development of gene therapies, It focuses on ophthalmological diseases for preserving visual autonomy of patients. The company was founded by Denis Cayet, Christian Hamel, Guylene Le Meur, Philippe Moullier, Vasiliki Kalatzis, and Michel Weberin March 2014 and is headquartered in Paris, France. | Biotechnology | Director/Board Member Director/Board Member | |
Truffle Capital SAS
 Truffle Capital SAS Investment ManagersFinance Truffle Capital SAS is an Independent Venture Capital firm founded in 2000. Truffle Capital is headquartered in Paris. | Investment Managers | Founder Private Equity Investor | |
Sanofi Pasteur
 Sanofi Pasteur BiotechnologyHealth Technology Sanofi Pasteur SA develops, manufactures and supplies vaccines. It provides vaccines for bacterial and viral diseases, including diphtheria, typhoid fever, and poliomyelitis. The company was founded in 1990 and is headquartered in Lyon, France. | Biotechnology | Director of Finance/CFO Chairman | |
Ms Medical Synergy SA
 Ms Medical Synergy SA Pharmaceuticals: MajorHealth Technology Ms Medical Synergy SA develops pharmaceutical products. It provides materials and products for the medical industry. The firm also offers seminars for the pharmaceutical area. The company was founded on February 3, 1986 and is headquartered in Geneva, Switzerland. | Pharmaceuticals: Major | Founder Director/Board Member | |
| VEXIM | Medical Specialties | Founder Director/Board Member | |
| SANOFI | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| Université Libre de Bruxelles | College/University | Doctorate Degree | |
ImmuneHealth ASBL
 ImmuneHealth ASBL Medical/Nursing ServicesHealth Services develops vaccines to cure disorders of the immune system. Its services include preclinical evaluation, clinical immunomonitoring, technical transfer, consulting and training services, cell, gene, and protein readout development, and clinical biomarker panels validation. The company was founded in 2007 and is headquartered in Gosselies, Belgium. | Medical/Nursing Services | Director/Board Member | |
DNAlytics SA
 DNAlytics SA Data Processing ServicesTechnology Services DNAlytics SA engages in the development of data-driven precision medicine solutions. The firm provides consultancy services; and academic medical, biological, and clinical research laboratories for the pharmaceutical, biotechnology and In-Vitro Diagnostic companies. It also offers software programs unde rthe REED, LiblineaR, jForest, and BLISS brands. The company was founded by Pierre Dupont and Thibault Helleputte in 2012 and is headquartered in Louvain-la-Neuve, Belgium. | Data Processing Services | Director/Board Member | |
4 for Cells SRL
 4 for Cells SRL Data Processing ServicesTechnology Services 4 for Cells SPRL provides business outsourcing services. The private company is based in Hastière, Belgium. The Belgian company was founded in 2011. François Lesage has been the CEO of the company since 2011. | Data Processing Services | Director/Board Member | |
| Eurobiotech SA | Director/Board Member | ||
LEUKOCARE AG
 LEUKOCARE AG Medical/Nursing ServicesHealth Services LeukoCare AG develops protein stabilization and protection solutions. The firm specializes in the development of protein stabilization and protection solutions for biopharmaceuticals, vaccines, medical devices, and diagnostics technologies. Its service areas encompass technology licensing, prototyping and product development, clinical registration, biological and chemical testing, and consulting. The company was founded by Martin Scholz in 2001 and is headquartered in Munich, Germany. | Medical/Nursing Services | Director/Board Member | |
| ELSALYS BIOTECH | Pharmaceuticals: Major | Director/Board Member | |
| Univac NV | Director/Board Member | ||
Q-Biologicals NV
 Q-Biologicals NV BiotechnologyHealth Technology Q-Biologicals NV operates as a bio pharma contract development and manufacturing organization. It provides process development and bio manufacturing services to customers in the biopharmaceutical industry. The company was founded in 2011 and is headquartered in Ghent, Belgium. | Biotechnology | Director/Board Member | |
| Merieux Group | Corporate Secretary | ||
Advanced BioScience Laboratories, Inc.
 Advanced BioScience Laboratories, Inc. Medical/Nursing ServicesHealth Services Advanced BioScience Laboratories, Inc. provides contract manufacturing and laboratory research services to advance leading vaccines and therapies from clinical development to the commercial market. It focuses on the development of therapeutics, vaccines, and other biologic products. The company was founded in 1961 and is headquartered in Rockville, MD. | Medical/Nursing Services | Director/Board Member | |
| Duke University School of Medicine | College/University | Doctorate Degree | |
GlaxoSmithKline Biologicals NV
 GlaxoSmithKline Biologicals NV BiotechnologyHealth Technology GlaxoSmithKline Biologicals SA manufactures vaccines for diseases such as hepatitis, influenza, rubella, and typhoid fever. Its activities include overall strategy, research and development, clinical trials, regulatory matters, production, quality control, marketing, and distribution. The company has partnership with WHO and UNICEF. GlaxoSmithKline Biologicals was founded in 1945 and is headquartered in Rixensart, Belgium. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Ogeda SA
 Ogeda SA Pharmaceuticals: MajorHealth Technology Ogeda SA discovers and develops small molecule drugs. It develops NK3 antagonists for the treatment of hormone-dependent pathologies in the field of Women's Health. The company was founded in 1994 and is headquartered in Gosselies, Spain. | Pharmaceuticals: Major | Director/Board Member | |
Lyon Pôle Bourse
 Lyon Pôle Bourse Financial ConglomeratesFinance Lyon Pôle Bourse engages in the provision of regional economy development services. The company was founded in 2009 and is headquartered in Lyon, France. | Financial Conglomerates | Director/Board Member | |
Ncardia SA
 Ncardia SA Miscellaneous Commercial ServicesCommercial Services Ncardia SA engages in drug discovery research and development. Its cardiac products encompass hiPSC-derived Pluricyte, Cardiomyocytes, Cor.4U cardiomyocytes and vCor.4U ventricular cardiomyocytes and FibroCor.4U cardiac fibroblasts. The company is headquartered in Gosselies, Belgium. | Miscellaneous Commercial Services | Director/Board Member | |
Mérieux NutriSciences Corp.
 Mérieux NutriSciences Corp. Miscellaneous Commercial ServicesCommercial Services Mérieux NutriSciences Corp. engages in the provision of scientific service solutions to food industries. It offers offers analytical and product development solutions to prevent health risks related to food and more generally to the use of everyday consumer products. It also offers digital solutions as part of its dedicated business The company was founded by John H. Silliker and Charles M?rieux in 1967 and is headquartered in Chicago, IL. | Miscellaneous Commercial Services | Director/Board Member | |
20Med Therapeutics BV
 20Med Therapeutics BV BiotechnologyHealth Technology 20Med Therapeutics BV operates as a biomedical company. It focuses on the development of biodegradable materials for biomedical applications and multifunctional nanosystems for controlled drug and gene delivery. The company was founded by Johan F. J. Engbersen in 2011 and is headquartered in Enschede, the Netherlands. | Biotechnology | Director/Board Member |
Statistik
International
| Frankreich | 27 |
| Belgien | 16 |
| Vereinigte Staaten | 6 |
| Schweiz | 3 |
| Deutschland | 2 |
Sektoral
| Health Technology | 26 |
| Consumer Services | 7 |
| Finance | 5 |
| Commercial Services | 5 |
| Health Services | 4 |
Operativ
| Director/Board Member | 213 |
| Corporate Officer/Principal | 78 |
| Founder | 53 |
| Chairman | 51 |
| Independent Dir/Board Member | 44 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Philippe Pouletty | 51 |
| Jean-Paul Prieels | 32 |
| Eric Jean Marie Leire | 27 |
| Walter Flamenbaum | 26 |
| Didier Hoch | 24 |
| Dominique Takizawa | 23 |
| Alexandre LeBeaut | 22 |
| Diane Jorkasky | 15 |
| David de Weese | 15 |
| Dominique Costantini | 15 |
| Maryvonne Hiance | 15 |
| Elsy Boglioli Hofman | 14 |
| Guy Chatelain | 13 |
| Alexis Peyroles | 10 |
| Emile Loria | 10 |
- Börse
- Insiders
- Gérard Tobelem
- Unternehmensverbindungen